Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease

Clin Rheumatol. 2019 Feb;38(2):609-610. doi: 10.1007/s10067-018-4357-y. Epub 2018 Nov 5.

Authors

Silvia Tamanini¹, Micaela Fredi^{2

3}, Francesca Crisafulli^{2

3}, Maria Grazia Lazzaroni^{2

3}, Angela Tincani^{2

3}, Franco Franceschini^{2

3}

Affiliations

¹ Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy. s.tamanini12@gmail.com.
² Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
³ Rheumatology and Clinical Immunology Unit, University of Brescia, 25123, Brescia, Italy.

PMID: 30397839
DOI: 10.1007/s10067-018-4357-y

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Arthralgia / etiology*
Female
Gastrointestinal Agents / therapeutic use
Humans
Inflammatory Bowel Diseases / drug therapy*
Inflammatory Bowel Diseases / physiopathology*
Male
Middle Aged
Recurrence
Spondylarthritis / etiology*

Substances

Antibodies, Monoclonal, Humanized
Gastrointestinal Agents
vedolizumab